Zusammenfassung
Vor allem bei Schlaganfallpatienten mit einem Alter unter 60 Jahren finden sich gehäuft seltene Schlaganfallursachen. Ihnen kommt große klinische Bedeutung zu, da bei korrekter Diagnosestellung eine spezifische Therapie eingeleitet werden kann, um weiteren Schlaganfällen vorzubeugen. Daher sollte bei jüngeren Patienten ein ischämischer Schlaganfall erst dann als kryptogen klassifiziert werden, nachdem eine umfassende Diagnostik durchgeführt wurde. Diese Übersichtsarbeit ausgewählter Literatur berichtet über seltene Schlaganfallursachen wie beispielsweise Gefäßerkrankungen, Morbus Fabry, Moyamoya oder hämatologische Erkrankungen, um dem Leser einen generellen Überblick zu geben.
Abstract
Stroke patients younger than 60 years of age frequently present with rare aetiologies of stroke. It is important to detect these rare aetiologies to initiate specific therapy to prevent future strokes in these patients. Therefore, ischaemic stroke in young patients should not be classified as cryptogenic unless a complete diagnostic work-up has been performed. This selected literature review covers rare stroke aetiologies, including vascular disorders, Morbus Fabry, Moyamoya or haematological disorders, to give the reader a general overview.
Schlüsselwörter
Schlaganfall - Ursache - selten - kryptogen
Keywords
stroke - aetiology - rare causes - cryptogenic
Literatur
-
1
Slovut D P, Olin J W.
Fibromuscular dysplasia.
N Engl J Med.
2004;
350
1862-1871
-
2
Luscher T F, Lie J T, Stanson A W et al.
Arterial fibromuscular dysplasia.
Mayo Clin Proc.
1987;
62
931-952
-
3
Olin J W.
Recognizing and managing fibromuscular dysplasia.
Cleve Clin J Med.
2007;
74
273-274, 277–282
-
4
Afifi A K, Godersky J C, Menezes A et al.
Cerebral hemiatrophy, hypoplasia of internal carotid artery, and intracranial aneurysm. A rare association occurring in an infant.
Arch Neurol.
1987;
44
232-235
-
5
Ide C, de Coene B, Mailleux P et al.
Hypoplasia of the internal carotid artery: a noninvasive diagnosis.
Eur Radiol.
2000;
10
1865-1870
-
6
Kubis N, Zuber M, Méder J F et al.
CT scan of the skull base in internal carotid artery hypoplasia.
Cerebrovasc Dis.
1996;
6
40-44
-
7
Brant-Zawadzki M.
Routine MR imaging of the internal carotid artery siphon: angiographic correlation with cervical carotid lesions.
AJR Am J Roentgenol.
1990;
155
359-363
-
8
Quint D J, Silbergleit R, Young W C.
Absence of the carotid canals at skull base CT.
Radiology.
1992;
182
477-481
-
9
Kayembe K N, Sasahara M, Hazama F.
Cerebral aneurysms and variations in the circle of Willis.
Stroke.
1984;
15
846-850
-
10
Given 2nd C A, Huang-Hellinger F, Baker M D et al.
Congenital absence of the internal carotid artery: case reports and review of the collateral circulation.
AJNR Am J Neuroradiol.
2001;
22
1953-1959
-
11
Friedman M H, Deters O J, Mark F F et al.
Arterial geometry affects hemodynamics. A potential risk factor for athersoclerosis.
Atherosclerosis.
1983;
46
225-231
-
12
Weibel J, Fields W S.
Tortuosity, coiling, and kinking of the internal carotid artery. I. Etiology and radiographic anatomy.
Neurology.
1965;
15
7-18
-
13
Cioffi F A, Meduri M, Tomasello F et al.
Kinking and coiling of the internal carotid artery: clinical-statistical observations and surgical perspectives.
J Neurosurg Sci.
1975;
19
15-22
-
14
Metz H, Murray-Leslie R M, Bannister R G et al.
Kinking of the internal carotid artery.
Lancet.
1961;
1
424-426
-
15
Stanton Jr P E, McClusky Jr D A, Lamis P A.
Hemodynamic assessment and surgical correction of kinking of the internal carotid artery.
Surgery.
1978;
84
793-802
-
16
Perdue G D, Barreca J P, Smith 3rd R B et al.
The significance of elongation and angulation of the carotid artery: a negative view.
Surgery.
1975;
77
45-52
-
17
Vannlx R S, Jorganson E J, Carter R.
Kinking of the internal carotid artery: clinical significance and surgical management.
Am J Surg.
1977;
134
82-89
-
18
Schievink W I, Limburg M, Oorthuys J W et al.
Cerebrovascular disease in Ehlers-Danlos syndrome type IV.
Stroke.
1990;
21
626-632
-
19
Germain D P.
Clinical and genetic features of vascular Ehlers-Danlos syndrome.
Ann Vasc Surg.
2002;
16
391-397
-
20
Oderich G S, Panneton J M, Bower T C et al.
The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience.
J Vasc Surg.
2005;
42
98-106
-
21
Debette S, Markus H S.
The genetics of cervical artery dissection: a systematic review.
Stroke.
2009;
40
e459-466
-
22
Pyeritz R E.
The Marfan syndrome.
Annu Rev Med.
2000;
51
481-510
-
23
Loeys B, De Backer J, van Acker P et al.
Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome.
Hum Mutat.
2004;
24
140-146
-
24
Wityk R J, Zanferrari C, Oppenheimer S.
Neurovascular complications of marfan syndrome: a retrospective, hospital-based study.
Stroke.
2002;
33
680-684
-
25
Zach V, Zhovtis S, Kirchoff-Torres K F et al.
Common carotid artery dissection: a case report and review of the literature.
J Stroke Cerebrovasc Dis.
2010;
[Epub ahead of print]
-
26
Steinke W, Schwartz A, Hennerici M.
Doppler color flow imaging of common carotid artery dissection.
Neuroradiology.
1990;
32
502-505
-
27
Noel M, Short J, Farooq M U.
Thrombolytic therapy in a patient with acute ischemic stroke caused by aortic dissection.
Clin Neurol Neurosurg.
2010;
112
695-696
-
28
Estrera A L, Miller 3rd C C, Madisetty J et al.
Ascending and transverse aortic arch repair: the impact of glomerular filtration rate on mortality.
Ann Surg.
2008;
247
524-529
-
29
Debette S, Leys D.
Cervical-artery dissections: predisposing factors, diagnosis, and outcome.
Lancet Neurol.
2009;
8
668-678
-
30
Chan C C, Paine M, O’Day J.
Carotid dissection: a common cause of Horner’s syndrome.
Clin Experiment Ophthalmol.
2001;
29
411-415
-
31
Kim Y K, Schulman S.
Cervical artery dissection: pathology, epidemiology and management.
Thromb Res.
2009;
123
810-821
-
32
Rigamonti A, Iurlaro S, Reganati P et al.
Cluster headache and internal carotid artery dissection: two cases and review of the literature.
Headache.
2008;
48
467-470
-
33
Waespe W, Niesper J, Imhof H G et al.
Lower cranial nerve palsies due to internal carotid dissection.
Stroke.
1988;
19
1561-1564
-
34
Krings T, Choi I S.
The many faces of intracranial arterial dissections.
Interv Neuroradiol.
2010;
16
151-160
-
35
Arnold M, Nedeltchev K, Sturzenegger M et al.
Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature.
Arch Neurol.
2002;
59
549-553
-
36
Goyal M S, Derdeyn C P.
The diagnosis and management of supraaortic arterial dissections.
Curr Opin Neurol.
2009;
22
80-89
-
37
Baumgartner R W.
Management of spontaneous dissection of the cervical carotid artery.
Acta Neurochir Suppl.
2010;
107
57-61
-
38
Georgiadis D, Arnold M, von Buedingen H C et al.
Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Neurology.
2009;
72
1810-1815
-
39
Lyrer P, Engelter S.
Antithrombotic drugs for carotid artery dissection.
Cochrane Database Syst Rev
2003;
CD000255
-
40
Benninger D H, Gandjour J, Georgiadis D et al.
Benign long-term outcome of conservatively treated cervical aneurysms due to carotid dissection.
Neurology.
2007;
69
486-487
-
41
Arauz A, Hoyos L, Espinoza C et al.
Dissection of cervical arteries: long-term follow-up study of 130 consecutive cases.
Cerebrovasc Dis.
2006;
22
150-154
-
42
Abou-Chebl A.
Cervical artery dissection.
Curr Treat Options Cardiovasc Med.
2009;
11
167-175
-
43
Li W, D’Ayala M, Hirshberg A et al.
Comparison of conservative and operative treatment for blunt carotid injuries: analysis of the National Trauma Data Bank.
J Vasc Surg.
2010;
51
593-599
-
44
Cohen J E, Ben-Hur T, Rajz G et al.
Endovascular stent-assisted angioplasty in the management of traumatic internal carotid artery dissections.
Stroke.
2005;
36
e45-47
-
45
Burke G M, Burke A M, Sherma A K et al.
Moyamoya disease: a summary.
Neurosurg Focus.
2009;
26
E11
-
46
Kraemer M, Heienbrok W, Berlit P.
Moyamoya disease in Europeans.
Stroke.
2008;
39
3193-3200
-
47
Jabbour R, Taher A, Shamseddine A et al.
Moyamoya syndrome with intraventricular hemorrhage in an adult with factor V Leiden mutation.
Arch Neurol.
2005;
62
1144-1146
-
48
Mehdorn H M.
Cerebral revascularization by EC-IC bypass – present status.
Acta Neurochir Suppl.
2008;
103
73-77
-
49
Ishii K, Morishige M, Anan M et al.
Superficial temporal artery-to-middle cerebral artery anastomosis with encephalo-duro-myo-synangiosis as a modified operative procedure for moyamoya disease.
Acta Neurochir Suppl.
2010;
107
95-99
-
50
Mateen F J, Monrad P A, Leep Hunderfund A N et al.
Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes.
Eur J Neurol.
2010;
18
218-225
-
51
Lipton R B, Bigal M E.
The epidemiology of migraine.
Am J Med.
2005;
118
(S 01)
3S-10S
-
52
The International Classification of Headache Disorders: 2nd edition.
Cephalalgia.
2004;
24
(S 01)
9-160
-
53
Etminan M, Takkouche B, Isorna F C et al.
Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.
BMJ.
2005;
330
63
-
54
Kurth T, Gaziano J M, Cook N R et al.
Migraine and risk of cardiovascular disease in women.
JAMA.
2006;
296
283-291
-
55
Kurth T, Schurks M, Logroscino G et al.
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study.
BMJ.
2008;
337
a636
-
56
MacClellan L R, Giles W, Cole J et al.
Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study.
Stroke.
2007;
38
2438-2445
-
57
Arboix A, Massons J, Garcia-Eroles L et al.
Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry.
Cephalalgia.
2003;
23
389-394
-
58
Sacquegna T, Andreoli A, Baldrati A et al.
Ischemic stroke in young adults: the relevance of migrainous infarction.
Cephalalgia.
1989;
9
255-258
-
59
Goadsby P J, Lipton R B, Ferrari M D.
Migraine – current understanding and treatment.
N Engl J Med.
2002;
346
257-270
-
60 Diener H C. Schlaganfall.. Stuttgart, New York: Thieme; 2004
-
61
James A H, Bushnell C D, Jamison M G et al.
Incidence and risk factors for stroke in pregnancy and the puerperium.
Obstet Gynecol.
2005;
106
509-516
-
62
Chang J, Elam-Evans L D, Berg C J et al.
Pregnancy-related mortality surveillance – United States, 1991–1999.
MMWR Surveill Summ.
2003;
52
1-8
-
63
Lanska D J, Kryscio R J.
Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis.
Stroke.
2000;
31
1274-1282
-
64
Ros H S, Lichtenstein P, Bellocco R et al.
Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified?.
Am J Obstet Gynecol.
2002;
186
198-203
-
65
Oehler J, Lichy C, Gandjour J et al.
[Dissection of four cerebral arteries after protracted birth].
Nervenarzt.
2003;
74
366-369
-
66
Jaigobin C, Silver F L.
Stroke and pregnancy.
Stroke.
2000;
31
2948-2951
-
67
van Lindert N H, Bienfait H P, Gratama J W et al.
Screening for aneurysm of the abdominal aorta: prevalence in patients with stroke or TIA.
Eur J Neurol.
2009;
16
602-607
-
68
Binaghi S, Saint-Maurice J P, Laurian C et al.
Embolic stroke complicating cervical aneurysm.
Cerebrovasc Dis.
2006;
22
196-198
-
69
Ildan F, Cetinalp E, Bagdatoglu H et al.
Giant fusiform aneurysm of the vertebro-basilar artery presenting with stroke.
Neurosurg Rev.
1995;
18
135-138
-
70
Steel J G, Thomas H A, Strollo P J.
Fusiform basilar aneurysm as a cause of embolic stroke.
Stroke.
1982;
13
712-716
-
71
Suzuki S, Inoue T, Haga S et al.
Stroke due to a fusiform aneurysm of the cervical vertebral artery: case report.
Neuroradiology.
1998;
40
19-22
-
72
Boggio P, Luna P C, Abad M E et al.
Fabry disease.
An Bras Dermatol.
2009;
84
367-376
-
73
Sims K, Politei J, Banikazemi M et al.
Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry.
Stroke.
2009;
40
788-794
-
74
Salviati A, Burlina A P, Borsini W.
Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.
Neurol Sci.
2010;
31
299-306
-
75
Moore D F, Altarescu G, Ling G S et al.
Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.
Stroke.
2002;
33
525-531
-
76
Martinez-Fernandez E, Gil-Peralta A, Garcia-Lozano R et al.
Mitochondrial disease and stroke.
Stroke.
2001;
32
2507-2510
-
77
Meschia J F, Brott T G, Brown Jr R D.
Genetics of cerebrovascular disorders.
Mayo Clin Proc.
2005;
80
122-132
-
78
Nonaka I.
Mitochondria DNA mutations induce variable clinical symptoms including „stroke” in younger and aged persons.
Intern Med.
1996;
35
924
-
79
Gilchrist J M, Sikirica M, Stopa E et al.
Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes.
Stroke.
1996;
27
1420-1423
-
80
Tzoulis C, Bindoff L A.
Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.
Stroke.
2009;
40
e15-17
-
81
Conforto A B, Yamamoto F I, Oba-Shinjo S M et al.
Screening for MELAS mutations in young patients with stroke of undetermined origin.
Arq Neuropsiquiatr.
2007;
65
371-376
-
82
Cathomas G, Szucs T D.
Bedeutung und Epidemiologie der Endokarditis.
Kardiovaskuläre Medizin.
2004;
7
181-184
-
83
Davenport J, Hart R G.
Prosthetic valve endocarditis 1976–1987. Antibiotics, anticoagulation, and stroke.
Stroke.
1990;
21
993-999
-
84
Hart R G, Foster J W, Luther M F et al.
Stroke in infective endocarditis.
Stroke.
1990;
21
695-700
-
85
Salgado A V.
Central nervous system complications of infective endocarditis.
Stroke.
1991;
22
1461-1463
-
86
Cooper H A, Thompson E C, Laureno R et al.
Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study.
Circulation.
2009;
120
585-591
-
87
Rabinstein A A.
Stroke in HIV-infected patients: a clinical perspective.
Cerebrovasc Dis.
2003;
15
37-44
-
88
Restrepo L, McArthur J.
Stroke and HIV infection.
Stroke.
2003;
34
e176-177
author reply e176–177
-
89
Modi G, Modi M, Mochan A.
Stroke and HIV – causal or coincidental co-occurrence?.
S Afr Med J.
2006;
96
1247-1248
-
90
Mochan A, Modi M, Modi G.
Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection.
J Neurol Neurosurg Psychiatry.
2005;
76
1455-1456
-
91
Qureshi A I.
HIV infection and stroke: if not protein S deficiency then what explains the relationship?.
J Neurol Neurosurg Psychiatry.
2005;
76
1331
-
92
Bova I Y, Bornstein N M, Korczyn A D.
Acute infection as a risk factor for ischemic stroke.
Stroke.
1996;
27
2204-2206
-
93
Grau A J, Buggle F, Steichen-Wiehn C et al.
Clinical and biochemical analysis in infection-associated stroke.
Stroke.
1995;
26
1520-1526
-
94
Zurru M C, Alonzo C, Brescacin L et al.
Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system.
Stroke.
2009;
40
1986-1990
-
95
Heuschmann P U, Neureiter D, Gesslein M et al.
Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study.
Stroke.
2001;
32
2253-2258
-
96
Masoud S A, Arami M A, Kucheki E.
Association between infection with Helicobacter pylori and cerebral noncardioembolic ischemic stroke.
Neurol India.
2005;
53
303-306; discussion 306–307
-
97
Paganini-Hill A, Lozano E, Fischberg G et al.
Infection and risk of ischemic stroke: differences among stroke subtypes.
Stroke.
2003;
34
452-457
-
98
Atik B, Johnston S C, Dean D.
Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.
PLoS One.
2010;
5
e11026
-
99
Macko R F, Ameriso S F, Gruber A et al.
Impairments of the protein C system and fibrinolysis in infection-associated stroke.
Stroke.
1996;
27
2005-2011
-
100
Ringleb P A, Strittmatter E I, Loewer M et al.
Cerebrovascular manifestations of Takayasu arteritis in Europe.
Rheumatology (Oxford).
2005;
44
1012-1015
-
101
Kim H J, Suh D C, Kim J K et al.
Correlation of neurological manifestations of Takayasu’s arteritis with cerebral angiographic findings.
Clin Imaging.
2005;
29
79-85
-
102
Tanaka F, Kawakami A, Iwanaga N et al.
Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
Intern Med.
2006;
45
313-316
-
103
No Y J, Lee E M, Lee D H et al.
Cerebral angiographic findings in thromboangiitis obliterans.
Neuroradiology.
2005;
47
912-915
-
104
Olin J W, Shih A.
Thromboangiitis obliterans (Buerger’s disease).
Curr Opin Rheumatol.
2006;
18
18-24
-
105
Comu S, Verstraeten T, Rinkoff J S et al.
Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy.
Stroke.
1996;
27
996-1001
-
106
Brown M M, Thompson A J, Wedzicha J A et al.
Sarcoidosis presenting with stroke.
Stroke.
1989;
20
400-405
-
107
Hodge M H, Williams R L, Fukui M B.
Neurosarcoidosis presenting as acute infarction on diffusion-weighted MR imaging: summary of radiologic findings.
AJNR Am J Neuroradiol.
2007;
28
84-86
-
108
Semb A G, Kvien T K, Aastveit A H et al.
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study.
Ann Rheum Dis.
2010;
69
1996-2001
-
109
Cantu-Brito C, Baizabal-Carvallo J F, Alonso-Juarez M et al.
The clinical significance of microembolic signals in patients with systemic lupus erythematosus.
Neurol Res.
2010;
32
134-138
-
110
Jimenez Caballero P E, Segura Martin T.
Cardioembolic stroke secondary to non-bacterial endocarditis in Wegener disease.
Eur J Neurol.
2007;
14
683-685
-
111
Lucivero V, Mezzapesa D M, Petruzzellis M et al.
Ischaemic stroke in progressive systemic sclerosis.
Neurol Sci.
2004;
25
230-233
-
112
Alexander E L, Craft C, Dorsch C et al.
Necrotizing arteritis and spinal subarachnoid hemorrhage in Sjogren syndrome.
Ann Neurol.
1982;
11
632-635
-
113
Bouton R, Capon A.
Stroke as initial manifestation of relapsing polychondritis.
Ital J Neurol Sci.
1994;
15
61-63
-
114
Hsu K C, Wu Y R, Lyu R K et al.
Aseptic meningitis and ischemic stroke in relapsing polychondritis.
Clin Rheumatol.
2006;
25
265-267
-
115
Slaviero F, Annes R D, Frighetto L et al.
Kohlmeier-Degos Disease (malignant atrophic papulosis) and neurologic involvement.
Arq Neuropsiquiatr.
2009;
67
692-694
-
116
Dilsen N, Konice M, Aral O et al.
Comparative study of the skin pathergy test with blunt and sharp needles in Behcet’s disease: confirmed specificity but decreased sensitivity with sharp needles.
Ann Rheum Dis.
1993;
52
823-825
-
117
Siva A, Altintas A, Saip S.
Behcet’s syndrome and the nervous system.
Curr Opin Neurol.
2004;
17
347-357
-
118
Demiroglu H, Ozcebe O I, Barista I et al.
Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet’s disease: a randomised trial.
Lancet.
2000;
355
605-609
-
119
Boesch S M, Plorer A L, Auer A J et al.
The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation study.
J Neurol Neurosurg Psychiatry.
2003;
74
542-544
-
120
Marinho J L, Piovesan E J, Leite Neto M P et al.
Clinical, neurovascular and neuropathological features in Sneddon’s syndrome.
Arq Neuropsiquiatr.
2007;
65
390-395
-
121
Lanthier S, Lortie A, Michaud J et al.
Isolated angiitis of the CNS in children.
Neurology.
2001;
56
837-842
-
122
Kadkhodayan Y, Alreshaid A, Moran C J et al.
Primary angiitis of the central nervous system at conventional angiography.
Radiology.
2004;
233
878-882
-
123
Danielsen A G, Weismann K, Jorgensen B B et al.
Incidence, clinical presentation and treatment of neurosyphilis in Denmark 1980–1997.
Acta Derm Venereol.
2004;
84
459-462
-
124
Berger C T, Wolbers M, Meyer P et al.
High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Rheumatology (Oxford).
2009;
48
258-261
-
125
Bley T A, Reinhard M, Hauenstein C et al.
Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis.
Arthritis Rheum.
2008;
58
2574-2578
-
126
Fries J F, Hunder G G, Bloch D A et al.
The American College of Rheumatology 1990 criteria for the classification of vasculitis.
Summary.
Arthritis Rheum.
1990;
33
1135-1136
-
127
Nesher G, Berkun Y, Mates M et al.
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Arthritis Rheum.
2004;
50
1332-1337
-
128
Sanahuja J, Marti-Fabregas J, Marti-Vilalta J L.
Carotid thrombus and cerebral infarction as the initial clinical manifestation of polycythemia vera.
Neurologia.
2005;
20
194-196
-
129
Zimmermann C, Walther E U, Scheidt W von et al.
Ischemic stroke in a 29-year-old man with left atrial spontaneous echoes and polycythemia vera.
J Neurol.
1999;
246
1201-1203
-
130
Jha S K, Anand A C, Sharma V et al.
Stroke at high altitude: Indian experience.
High Alt Med Biol.
2002;
3
21-27
-
131
Gonthier A, Bogousslavsky J.
Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature.
Rev Neurol (Paris).
2004;
160
1029-1039
-
132
Arboix A, Besses C, Acin P et al.
Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases.
Stroke.
1995;
26
1463-1466
-
133
Mallada-Frechin J, Abellan-Miralles I, Medrano V et al.
Ischemic stroke as a presentation of essential thrombocythemia. Four case reports.
Rev Neurol.
2004;
38
1032-1034
-
134
Muniz A E.
Myocardial infarction and stroke as the presenting symptoms of acute myeloid leukemia.
J Emerg Med.
2009;
[Epub ahead of print]
-
135
Saitoh E, Sugita K, Kurosawa H et al.
Cerebral infarction in acute promyelocytic leukemia at initial presentation.
Acta Paediatr Jpn.
1995;
37
710-712
-
136
Benito-Leon J, Sanchez J, Osorio S et al.
Ischemic stroke as first manifestation of chronic myelogenous leukemia.
Rev Neurol.
1999;
29
391-392
-
137
Robak T, Gora-Tybor J, Tybor K et al.
Richter’s syndrome in the brain first manifested as an ischaemic stroke.
Leuk Lymphoma.
2004;
45
1261-1267
-
138
Rogers L R.
Cerebrovascular complications in cancer patients.
Neurol Clin.
2003;
21
167-192
-
139
Morris B, Partap S, Yeom K et al.
Cerebrovascular disease in childhood cancer survivors: A Children’s Oncology Group Report.
Neurology.
2009;
73
1906-1913
-
140
Adams R J.
Stroke prevention and treatment in sickle cell disease.
Arch Neurol.
2001;
58
565-568
-
141
Portnoy B A, Herion J C.
Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia.
Ann Intern Med.
1972;
76
643-652
-
142
Gerald B, Sebes J I, Langston J W.
Cerebral infarction secondary to sickle cell disease: arteriographic findings.
AJR Am J Roentgenol.
1980;
134
1209-1212
-
143
Jeffries B F, Lipper M H, Kishore P R.
Major intracerebral arterial involvement in sickle cell disease.
Surg Neurol.
1980;
14
291-295
-
144
Yager J Y, Hartfield D S.
Neurologic manifestations of iron deficiency in childhood.
Pediatr Neurol.
2002;
27
85-92
-
145
Dan K.
Thrombocytosis in iron deficiency anemia.
Intern Med.
2005;
44
1025-1026
-
146
Nagai T, Komatsu N, Sakata Y et al.
Iron deficiency anemia with marked thrombocytosis complicated by central retinal vein occlusion.
Intern Med.
2005;
44
1090-1092
-
147
Belman A L, Roque C T, Ancona R et al.
Cerebral venous thrombosis in a child with iron deficiency anemia and thrombocytosis.
Stroke.
1990;
21
488-493
-
148
Bruggers C S, Ware R, Altman A J et al.
Reversible focal neurologic deficits in severe iron deficiency anemia.
J Pediatr.
1990;
117
430-432
-
149
Hartfield D S, Lowry N J, Keene D L et al.
Iron deficiency: a cause of stroke in infants and children.
Pediatr Neurol.
1997;
16
50-53
-
150
Huttenlocher P R, Smith D B.
Acute infantile hemiplegia associated with thrombocytosis.
Dev Med Child Neurol.
1968;
10
621-625
-
151
Knizley Jr H, Noyes W D.
Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis.
Arch Intern Med.
1972;
129
483-486
-
152
Tekin D, Yavuzer S, Tekin M et al.
Possible effects of antioxidant status on increased platelet aggregation in childhood iron-deficiency anemia.
Pediatr Int.
2001;
43
74-77
-
153
Park M S, Kim B C, Kim I K et al.
Cerebral infarction in IgG multiple myeloma with hyperviscosity.
J Korean Med Sci.
2005;
20
699-701
-
154
Perez-Diaz H, Serrano-Pozo A, Gonzalez-Marcos J R.
Multiple myeloma as a treatable cause of stroke: clinical case and review of the literature.
Neurologia.
2007;
22
54-57
-
155
Röth A, Dührsen U.
Paroxysmale nächtliche Hämoglobinurie: Pathogenese, Diagnostik und Behandlung.
Deutsches Arzteblatt.
2007;
104
192-197
-
156
Audebert H J, Planck J, Eisenburg M et al.
Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients.
J Neurol.
2005;
252
1379-1386
-
157
Poulou L S, Vakrinos G, Pomoni A et al.
Stroke in paroxysmal nocturnal haemoglobinuria: patterns of disease and outcome.
Thromb Haemost.
2007;
98
699-701
-
158
Naithani R, Mahapatra M, Dutta P et al.
Paroxysmal nocturnal hemoglobinuria in childhood and adolescence – a retrospective analysis of 18 cases.
Indian J Pediatr.
2008;
75
575-578
-
159
Aksay E, Kiyan S, Ersel M et al.
Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke.
Emerg Med J.
2006;
23
e51
-
160
Bennett C L, Connors J M, Carwile J M et al.
Thrombotic thrombocytopenic purpura associated with clopidogrel.
N Engl J Med.
2000;
342
1773-1777
-
161
Fukusako T, Yamashita H, Omoto M et al.
Case of thrombotic thrombocytopenic purpura associated with clopidogrel.
Rinsho Shinkeigaku.
2007;
47
635-638
-
162
Verbeke L, Delforge M, Dierickx D.
Current insight into thrombotic thrombocytopenic purpura.
Blood Coagul Fibrinolysis.
2010;
21
3-10
-
163
Wijdicks E F, Scott J P.
Stroke in the medical intensive-care unit.
Mayo Clin Proc.
1998;
73
642-646
-
164
Cushman M, Rosendaal F R, Psaty B M et al.
Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
Thromb Haemost.
1998;
79
912-915
-
165
Hankey G J, Eikelboom J W, van Bockxmeer F M et al.
Inherited thrombophilia in ischemic stroke and its pathogenic subtypes.
Stroke.
2001;
32
1793-1799
-
166
Ridker P M, Hennekens C H, Lindpaintner K et al.
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
N Engl J Med.
1995;
332
912-917
-
167
Longstreth Jr W T, Rosendaal F R, Siscovick D S et al.
Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A).
Stroke.
1998;
29
577-580
-
168
Kenet G, Sadetzki S, Murad H et al.
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Stroke.
2000;
31
1283-1288
-
169
Zenz W, Bodo Z, Plotho J et al.
Factor V Leiden and prothrombin gene G 20 210 A variant in children with ischemic stroke.
Thromb Haemost.
1998;
80
763-766
-
170
Ridker P M, Hennekens C H, Miletich J P.
G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.
Circulation.
1999;
99
999-1004
-
171
Smiles A M, Jenny N S, Tang Z et al.
No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study.
Thromb Haemost.
2002;
87
614-621
-
172
De Stefano V, Chiusolo P, Paciaroni K et al.
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients.
Blood.
1998;
91
3562-3565
-
173
Lalouschek W, Schillinger M, Hsieh K et al.
Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke / transient ischemic attack up to the age of 60 years.
Stroke.
2005;
36
1405-1409
-
174
Camerlingo M, Finazzi G, Casto L et al.
Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adults.
Neurology.
1991;
41
1371-1373
-
175
De Stefano V, Leone G, Micalizzi P et al.
Arterial thrombosis as clinical manifestation of congenital protein C deficiency.
Ann Hematol.
1991;
62
180-183
-
176
Girolami A, Simioni P, Lazzaro A R et al.
Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study.
Thromb Haemost.
1989;
61
144-147
-
177
Green D, Otoya J, Oriba H et al.
Protein S deficiency in middle-aged women with stroke.
Neurology.
1992;
42
1029-1033
-
178
Grewal R P, Goldberg M A.
Stroke in protein C deficiency.
Am J Med.
1990;
89
538-539
-
179
Kohler J, Kasper J, Witt I et al.
Ischemic stroke due to protein C deficiency.
Stroke.
1990;
21
1077-1080
-
180
Koller H, Stoll G, Sitzer M et al.
Deficiency of both protein C and protein S in a family with ischemic strokes in young adults.
Neurology.
1994;
44
1238-1240
-
181
Martinez H R, Rangel-Guerra R A, Marfil L J.
Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults.
Stroke.
1993;
24
19-25
-
182
Douay X, Lucas C, Caron C et al.
Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke.
Acta Neurol Scand.
1998;
98
124-127
-
183
Munts A G, van Genderen P J, Dippel D W et al.
Coagulation disorders in young adults with acute cerebral ischaemia.
J Neurol.
1998;
245
21-25
-
184
Chan A K, deVeber G.
Prothrombotic disorders and ischemic stroke in children.
Semin Pediatr Neurol.
2000;
7
301-308
-
185
Moster M L.
Coagulopathies and arterial stroke.
J Neuroophthalmol.
2003;
23
63-71
-
186
Quattrone A, Colucci M, Donati M B et al.
Stroke in two young siblings with congenital dysfibrinogenemia.
Ital J Neurol Sci.
1983;
4
229-232
-
187
Arima T, Motomura M, Nishiura Y et al.
Cerebral infarction in a heterozygote with variant antithrombin III.
Stroke.
1992;
23
1822-1825
-
188
deVeber G, Monagle P, Chan A et al.
Prothrombotic disorders in infants and children with cerebral thromboembolism.
Arch Neurol.
1998;
55
1539-1543
-
189
Brey R L, Hart R G, Sherman D G et al.
Antiphospholipid antibodies and cerebral ischemia in young people.
Neurology.
1990;
40
1190-1196
-
190
Brey R L, Stallworth C L, McGlasson D L et al.
Antiphospholipid antibodies and stroke in young women.
Stroke.
2002;
33
2396-2400
-
191
Nencini P, Baruffi M C, Abbate R et al.
Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia.
Stroke.
1992;
23
189-193
-
192
Toschi V, Motta A, Castelli C et al.
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause.
Stroke.
1998;
29
1759-1764
-
193
Turiel M, Sarzi-Puttini P, Peretti R et al.
Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study.
Stroke.
2005;
36
1490-1494
Dr. Oliver Kastrup
Neurologie, Universitätsklinikum Essen
Hufelandstr. 55
45147 Essen
Email: oliver.kastrup@uk-essen.de
